263 related articles for article (PubMed ID: 19536745)
1. A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety.
Kikuchi T; Gittins J
Stat Med; 2009 Aug; 28(18):2293-306. PubMed ID: 19536745
[TBL] [Abstract][Full Text] [Related]
2. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
Kikuchi T; Gittins J
Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
[TBL] [Abstract][Full Text] [Related]
3. The choice of sample size: a mixed Bayesian / frequentist approach.
Pezeshk H; Nematollahi N; Maroufy V; Gittins J
Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
[TBL] [Abstract][Full Text] [Related]
4. Optimal sample size determinations from an industry perspective based on the expected value of information.
Willan AR
Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
[TBL] [Abstract][Full Text] [Related]
5. A decision theoretic approach to sample size determination in clinical trials.
Gittins JC; Pezeshk H
J Biopharm Stat; 2002 Nov; 12(4):535-51. PubMed ID: 12477073
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
Kikuchi T; Pezeshk H; Gittins J
Stat Med; 2008 Jan; 27(1):68-82. PubMed ID: 17566967
[TBL] [Abstract][Full Text] [Related]
7. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
Brutti P; De Santis F; Gubbiotti S
Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
[TBL] [Abstract][Full Text] [Related]
8. A Bayesian approach for incorporating economic factors in sample size design for clinical trials of individual drugs and portfolios of drugs.
Patel NR; Ankolekar S
Stat Med; 2007 Nov; 26(27):4976-88. PubMed ID: 17579924
[TBL] [Abstract][Full Text] [Related]
9. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
10. Sample size determination for phase II clinical trials based on Bayesian decision theory.
Stallard N
Biometrics; 1998 Mar; 54(1):279-94. PubMed ID: 9544522
[TBL] [Abstract][Full Text] [Related]
11. Bayesian estimation of cost-effectiveness: an importance-sampling approach.
Heitjan DF; Li H
Health Econ; 2004 Feb; 13(2):191-8. PubMed ID: 14737756
[TBL] [Abstract][Full Text] [Related]
12. Using covariates to reduce uncertainty in the economic evaluation of clinical trial data.
Vázquez-Polo FJ; Negrín Hernández MA; López-Valcárcel BG
Health Econ; 2005 Jun; 14(6):545-57. PubMed ID: 15497202
[TBL] [Abstract][Full Text] [Related]
13. A seamless phase II/III design with sample-size re-estimation.
Bischoff W; Miller F
J Biopharm Stat; 2009 Jul; 19(4):595-609. PubMed ID: 20183428
[TBL] [Abstract][Full Text] [Related]
14. The value of information and optimal clinical trial design.
Willan AR; Pinto EM
Stat Med; 2005 Jun; 24(12):1791-806. PubMed ID: 15806619
[TBL] [Abstract][Full Text] [Related]
15. Optimal sample size for a series of pilot trials of new agents.
Yao TJ; Begg CB; Livingston PO
Biometrics; 1996 Sep; 52(3):992-1001. PubMed ID: 8805764
[TBL] [Abstract][Full Text] [Related]
16. Optimal choice of the number of treatments to be included in a clinical trial.
Stallard N; Posch M; Friede T; Koenig F; Brannath W
Stat Med; 2009 Apr; 28(9):1321-38. PubMed ID: 19243083
[TBL] [Abstract][Full Text] [Related]
17. An economic approach to clinical trial design and research priority-setting.
Claxton K; Posnett J
Health Econ; 1996; 5(6):513-24. PubMed ID: 9003938
[TBL] [Abstract][Full Text] [Related]
18. A sample-size-optimal Bayesian procedure for sequential pharmaceutical trials.
Cressie N; Biele J
Biometrics; 1994 Sep; 50(3):700-11. PubMed ID: 7981396
[TBL] [Abstract][Full Text] [Related]
19. Bayesian estimation of cost-effectiveness from censored data.
Heitjan DF; Kim CY; Li H
Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
[TBL] [Abstract][Full Text] [Related]
20. An opportunity cost approach to sample size calculation in cost-effectiveness analysis.
Gafni A; Walter SD; Birch S; Sendi P
Health Econ; 2008 Jan; 17(1):99-107. PubMed ID: 17497751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
